Summary
The urinary excretion of nortriptyline (NT) and five of its metabolites was studied by quantitative gas chromatography in 22 twins and 7 unrelated healthy subjects after single (1 mg/kg) and multiple oral doses (0.4 mg/kg t.i.d.) of NT hydrochloride. A mean recovery of 62% of the dose was found after both single and multiple doses. The metabolite pattern in the urine was qualitatively and quantitatively identical in the two regimes, but there were marked variations in the pattern of metabolites between individuals. The disappearance rate of NT from the plasma was mainly determined by the metabolism of NT to 10-hydroxynortriptyline, which varied considerably between individuals. The data suggest that in certain rapid NT metabolizers, the upper limit for the overall clearance of NT from the plasma (if extrahepatic metabolism is assumed to be negligible) might be set by the blood flow through the liver.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexanderson, B.: Pharmacokinetics of nortriptyline in man after single and multiple oral doses: The predictability of steady-state plasma concentrations from single-dose plasma-level data. Europ. J. clin. Pharmacol.4, 82–91 (1972a).
Alexanderson, B.: Pharmacokinetics of desmethylimipramine and nortriptyline in man after single and multiple oral doses — a cross-over study. Europ. J. clin. Pharmacol.5, 1–10 (1972).
Alexanderson, B., Borgå, O., Alván, G.: The availability of orally administered nortriptyline. Europ. J. clin. Pharmacol.5, 181–185 (1973).
Alexanderson B., Evans, D.A.P., Sjöqvist, F.: Steady-state plasma levels of nortriptyline in twins: Influence of genetic factors and drug therapy. Brit. med. J.1969 IV, 764–768.
Amundson, M.E., Manthey, J.A.: Excretion of nortriptyline hydrochloride in man. I. Detection and determination of urinary nortriptyline. J. Pharm. Sci.55, 277–280 (1966).
Bahr, C. von, Borgå, O.: Uptake, metabolism and excretion of desmethylimipramine and its metabolites in the isolated perfused rat liver. Acta Pharmacol. Toxicol.29, 359–374 (1971).
Bahr, C. von, Borgå, O., Rowland, M.: Kinetics of nortriptyline (NT) in ratsin vivo and in the isolated perfused liver: demonstration of a “first pass disappearance” of NT in the liver. Pharmacology, in press.
Bertilsson, L., Alexanderson, B.: Stereospecific hydroxylation of nortriptyline in man in relation to interindividual differences in its steady-state plasma level. Europ. J. clin. Pharmacol.4, 201–205 (1972).
Bickel, M.H., Minder, R.: Metabolism and biliary excretion of the lipophilic drug molecules, imipramine and desmethylimipramine in the rat — I. Experimentsin vivo and with isolated perfused livers. Biochem. Pharmacol.19, 2425–2435 (1970).
Borgå, O., Garle, M.: A gas chromatographic method for the determination of nortriptyline and some of its metabolites in human plasma and urine. J. Chromatogr.68, 77–88 (1972).
Borgå, O., Palmér, L., Linnarsson, A., Holmstedt, B.: Quantitative determination of nortriptyline and desmethylnortriptyline in human plasma by combined gas chromatography — mass spectrometry. Anal. Letters.4, 837–849 (1971).
De Leenheer, A., Heyndrickx, A.: Identification of a major metabolite of nortriptyline in human urine. J. Pharm. Sci.60, 1403–1405 (1971).
Gibaldi, M., Boyes, R.N., Feldman, S.: Influence of first-pass effect on availability of drugs on oral administration. J. Pharm. Sci.60, 1338–1340 (1971).
Hammar, C.G., Alexanderson, B., Holmstedt, B., Sjöqvist, F.: Gas chromatography — mass spectrometry of nortriptyline in body fluids of man. Clin. Pharmacol. Therap.12, 496–505 (1971).
Hammer, W.M., Brodie, B.B.: Application of isotope derivative technique to assay of secondary amines: estimation of desipramine by acetylation with H8-acetic anhydride. J. Pharmacol. exp. Ther.157, 503–508 (1967).
Hammer, W., Ideström, C.M., Sjöqvist, F.: Chemical control of anti-depressant drug therapy. In: Garattini, S., Dukes, M.N.G. (eds), Proc. First Internat. Symp. Antidepressant Drugs, Milan, Italy, 1966, Excerpta Med. Internat. Congr. Ser. No.122, 301–310 (1967).
Knapp, D.R., Gaffney, T.E., McMahon, R.E., Kiplinger, G.: Studies on human urinary and biliary metabolites of nortriptyline with stable isotope labelling. J. Pharmacol. exp. Ther.180, 784–790 (1972).
Maffri Facino, R., Santagostino, G., Corona, G.L.: Presence of an acid metabolite of amitriptyline in rabbit urine. Biochem. Pharmacol.19, 1503–1505 (1970).
Price, H.L., Kovnat, P.J., Safer, J.M., Conner, E.H., Price, M.L.: The uptake of thiopental by body tissues and its relation to the duration of narcosis. Clin. Pharmacol. Ther.1, 16–22 (1960).
Sjöqvist, F., Hammer, W., Borgå, O., Azarnoff, D.L.: Pharmacological significance of the plasma level of monomethylated tricyclic antidepressants. Proc. Coll. Internat. Neuro-psychopharmacol. Tarragona, Spain, April 1968. Excerpta Med. Internat. Congr. Ser. No180, 128–136 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alexanderson, B., Borgå, O. Urinary excretion of nortriptyline and five of its metabolites in man after single and multiple oral doses. Eur J Clin Pharmacol 5, 174–180 (1973). https://doi.org/10.1007/BF00564899
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00564899